Citymeds Diagnostics Private Limited
Diagnostic center providing services since 2021, based in Madhya Pradesh.
2021 | Indore, Madhya Pradesh (India) | Active
Citymeds Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.14 M
- Paid Up Capital ₹ 0.14 M
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.73 M
About Citymeds Diagnostics
Citymeds Diagnostics Private Limited (CDPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 June 2021 (Three years and seven months 28 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.14 M and a paid-up capital of Rs 0.14 M.
The company currently has active open charges totaling ₹3.73 M.
Pradeepsingh Thakur and Yashavant Singh serve as directors at the Company.
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110MP2021PTC056490
- Company No.
056490
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jun 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Healthcare
Who are the key members and board of directors at Citymeds Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeepsingh Thakur  | Director | 30-Jun-2021 | Current |
| Yashavant Singh | Director | 30-Jun-2021 | Current |
Financial Performance of Citymeds Diagnostics.
Enhance accessibility to Citymeds Diagnostics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Citymeds Diagnostics?
Unlock access to Citymeds Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹3.73 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 0.37 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2021 | Others | ₹3.73 M | Open |
How Many Employees Work at Citymeds Diagnostics?
Citymeds Diagnostics has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Citymeds Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Citymeds Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
